Inhaltsbereich
| 226 Einträge | « ‹ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 › » |
Seite 7 / 12
 Druckansicht
|
| MDR1 RNA transcripts do not indicate long-term prognosis in colorectal carcinomas. |
| Zöchbauer S, Wallner J, Haider K, Depisch D, Huber H, Pirker R |
| European journal of cancer (Oxford, England : 1990). 1997 Nov 3. pii: S0959804997001391 |
| PMID: 9337699 |
| Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy. |
| Berger T, Malayeri R, Doppelbauer A, Krajnik G, Huber H, Auff E, Pirker R |
| European journal of cancer (Oxford, England : 1990). 1997 Nov 3. pii: S0959804997001032 |
| PMID: 9337680 |
| Immunocytochemical detection of the multidrug resistance-associated protein and P-glycoprotein in acute myeloid leukemia: impact of antibodies, sample source and disease status. |
| Filipits M, Suchomel RW, Lechner K, Pirker R |
| Leukemia. 1997 Jul 17. |
| PMID: 9204994 |
| Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas. |
| Fillpits M, Suchomel RW, Dekan G, Stiglbauer W, Haider K, Depisch D, Pirker R |
| British journal of cancer. 1997 Feb 20. pmc: PMC2063277 |
| PMID: 9010028 |
| Multidrug resistance in leukemias and its reversal. |
| Malayeri R, Filipits M, Suchomel RW, Zöchbauer S, Lechner K, Pirker R |
| Leukemia & lymphoma. 1997 Apr 11. doi: 10.3109/10428199609054853 |
| PMID: 9031075 |
| MRP and MDR1 gene expression in primary breast carcinomas. |
| Filipits M, Suchomel RW, Dekan G, Haider K, Valdimarsson G, Depisch D, Pirker R |
| Clinical cancer research : an official journal of the American Association for Cancer Research. 1999 Feb 9. |
| PMID: 9816292 |
| Clinical relevance of drug resistance genes in malignant disease. |
| Filipits M, Suchomel RW, Zöchbauer S, Malayeri R, Pirker R |
| Leukemia. 1996 Jul 26. |
| PMID: 8656694 |
| Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC). |
| Pirker R, Krajnik G, Zöchbauer S, Malayeri R, Kneussl M, Huber H |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 1996 Mar 27. |
| PMID: 8589023 |
| P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia. |
| Zöchbauer S, Gsur A, Brunner R, Kyrle PA, Lechner K, Pirker R |
| Leukemia. 1994 Jul 13. |
| PMID: 7516030 |
| MDR1 gene expression in chronic lymphocytic leukemia. |
| Wallner J, Gisslinger H, Gisslinger B, Gsur A, Götzl M, Zöchbauer S, Pirker R |
| Leukemia & lymphoma. 1994 Sep 2. doi: 10.3109/10428199409056298 |
| PMID: 7914128 |
| MDR1 gene expression in primary colorectal carcinomas. |
| Pirker R, Wallner J, Gsur A, Götzl M, Zöchbauer S, Scheithauer W, Depisch D |
| British journal of cancer. 1993 Nov 15. pmc: PMC1968613 |
| PMID: 8398695 |
| Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C. |
| Scheithauer W, Kornek G, Haider K, Kwasny W, Schenk T, Pirker R, Depisch D |
| Breast cancer research and treatment. 1993 Nov 16. |
| PMID: 8400323 |
| MDR1 gene expression and treatment outcome in acute myeloid leukemia. |
| Pirker R, Wallner J, Geissler K, Linkesch W, Haas OA, Bettelheim P, Hopfner M, Scherrer R, Valent P, Havelec L |
| Journal of the National Cancer Institute. 1991 Jun 6. |
| PMID: 2023272 |
| Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia. |
| Pirker R, Goldstein LJ, Ludwig H, Linkesch W, Lechner C, Gottesman MM, Pastan I |
| Cancer communications. 1990 Aug 23. |
| PMID: 2639725 |
| Immunotoxins against solid tumors. |
| Pirker R |
| Journal of cancer research and clinical oncology. 1988 Oct 11. |
| PMID: 3045130 |
| Third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer. |
| Pirker R |
| Current opinion in oncology. 2015 Dec 30. doi: 10.1097/CCO.0000000000000260 |
| PMID: 26720671 |
| Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality. |
| Pavo N, Raderer M, Hülsmann M, Neuhold S, Adlbrecht C, Strunk G, Goliasch G, Gisslinger H, Steger GG, Hejna M, Köstler W, Zöchbauer-Müller S, Marosi C, Kornek G, Auerbach L, Schneider S, Parschalk B, Scheithauer W, Pirker R, Drach J, Zielinski C, Pacher R |
| Heart (British Cardiac Society). 2015 Sep 28. pii: heartjnl-2015-307848. doi: 10.1136/heartjnl-2015-307848 |
| PMID: 26416836 |
| Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine? |
| Pirker R, Filipits M |
| Translational lung cancer research. 2016 Jan 22. doi: 10.3978/j.issn.2218-6751.2015.03.08. pii: tlcr-04-06-797 |
| PMID: 26798590 |
| Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer. |
| Brambilla E, Le Teuff G, Marguet S, Lantuejoul S, Dunant A, Graziano S, Pirker R, Douillard JY, Le Chevalier T, Filipits M, Rosell R, Kratzke R, Popper H, Soria JC, Shepherd FA, Seymour L, Tsao MS |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Feb 1. pii: JCO.2015.63.0970. doi: 10.1200/JCO.2015.63.0970 |
| PMID: 26834066 |
| Prognostic and predictive effect of TP53 mutations in non-small cell lung cancer patients from adjuvant cisplatin-based therapy randomized trials: a LACE-bio pooled analysis. |
| Ma X, Le Teuff G, Lacas B, Tsao MS, Graziano S, Pignon JP, Douillard JY, Le Chevalier T, Seymour L, Filipits M, Pirker R, Janne P, Shepherd FA, Brambilla E, Soria JC, Hainaut P |
| Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016 Feb 16. pii: S1556-0864(16)00359-2. doi: 10.1016/j.jtho.2016.02.002 |
| PMID: 26899019 |
| 226 Einträge | « ‹ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 › » |
Seite 7 / 12
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
